Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Big Ten Cancer Research Consortium
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC
Shandong Cancer Hospital and Institute
First Affiliated Hospital of Zhejiang University
Lisata Therapeutics, Inc.
Elevation Oncology
Insel Gruppe AG, University Hospital Bern
Beijing Biostar Pharmaceuticals Co., Ltd.
Seoul National University Hospital
Seoul National University Hospital
Basilea Pharmaceutica
Academic and Community Cancer Research United
PCI Biotech AS
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Zhejiang Cancer Hospital
University of Edinburgh
National Institutes of Health Clinical Center (CC)
Sunnybrook Health Sciences Centre
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Khon Kaen University
ASLAN Pharmaceuticals
National Cancer Institute (NCI)
University of Pittsburgh
PrECOG, LLC.
Montefiore Medical Center
Wake Forest University Health Sciences
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
National Cancer Institute (NCI)
Galectin Therapeutics Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Stanford University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)